Bonalive Biomaterials
Jort (Johannes Arend) Kooistra is an experienced executive with a robust background in commercial operations and healthcare innovation. Currently serving as the Global Vice President of Commercial Operations at Bonalive Biomaterials and a Board Member at Rugby Nederland, Jort is also a co-owner at See Company and a shareholder at Medea Medical. Previous leadership roles include Chief Executive Officer and co-owner at Haerst B.V., Director BeNeLux at BONESUPPORT AB, and CEO (a.i.) at both MedEye and VPI | Spectacular Visualization. Jort holds multiple MBA degrees from prestigious institutions, including Harvard Business School and Northwestern University, and a BSc in Physical Therapy from HU University of Applied Sciences Utrecht.
This person is not in any teams
This person is not in any offices
Bonalive Biomaterials
As the world seeks answers to the growing threat of antibiotic resistance, Bonalive represents a new standard in patient care. Evolving at the intersection of technology and human biology, our Smart Healing™ technologies reduce antibiotic treatments and enable a better quality of life for patients. Smart Healing™ encompasses our commitment to our customers. It defines everything we do, in providing patients and surgeons well-proven and safe bone regenerative products in orthopedics, trauma, spine, septic bone and ear surgery. It's time to heal smarter. #SmartHealing For indications, contraindications, warnings and precautions related to Bonalive® products refer to the IFU within the product package. This site is not intended for US customers.